Photo of John Arszulowicz

John Arszulowicz is an associate in Crowell & Moring’s Washington, D.C. office and a member of the Tax and International Trade groups. John’s practice focuses on advising clients on tax controversy, tax planning, trade remedies, and import regulatory compliance matters. John also supports the firm’s Corporate Group on asset-based and real estate loans and loan restructures. In addition, John supports the firm’s U.S. Food and Drug Administration (FDA) matters. John’s experience includes researching and summarizing numerous compliance and liability concerns for the distribution and labeling of FDA-regulated products granted an Emergency Use Authorization or enforcement discretion exception during the nation’s COVID-19 response. Prior to joining Crowell & Moring, John was a credentialed agency official at the FDA, where he completed the FDA’s basic food and drug law course. John was also a summer intern at the U.S. Department of Labor, Office of the Solicitor. During this summer internship, John was involved in a variety of Employee Retirement Income Security Act of 1974 (ERISA) matters. John was selected as a Gary S. Tell ERISA Litigation Scholar.

The government has lost another battle in its fight to prevent refunds of certain excise taxes paid by importers. Earlier this year, the U.S. Court of International Trade (CIT) struck down a regulation issued by the Department of the Treasury and U.S. Customs and Border Protection (Treasury and CBP, collectively the agencies) designed to limit

The Office of the U.S. Trade Representative (USTR) is seeking comments to remove Section 301 tariffs on certain Chinese imported products that could help support the United States COVID-19 response. The USTR recently granted approximately 200 exclusions that covered personal protective equipment products, including medical masks, examination gloves, antiseptic wipes, and other medical-care related items